Authors: BLANKENSHIP JC GODFREY NK BALOG G DEMKO SL TCHENG JE

Citation: Jc. Blankenship et al., HOW DID ACIXIMAB DECREASE ISCHEMIC COMPLICATIONS DURING CORONARY INTERVENTION IN EPISTENT - ANALYSIS OF IN-LAB ADVERSE EVENTS, Circulation, 98(17), 1998, pp. 3018-3018

Authors: LINCOFF AM BOOTH JE GODFREY NK KRAMER J KELLY T TOPOL EJ

Citation: Am. Lincoff et al., PERIPROCEDURAL MYOCARDIAL INFARCTIONS PREVENTED BY IIB-IIIA BLOCKADE ARE CLINICALLY AND ANGIOGRAPHICALLY MANIFEST AND LARGE - THE EPISTENT EXPERIENCE, Circulation, 98(17), 1998, pp. 4019-4019

Authors: LINCOFF AM TCHENG JE CALIFF RM CABOT CF BOOTH JE GODFREY NK TOPOL EJ

Citation: Am. Lincoff et al., THE EPISTENT TRIAL AT 6 MONTHS - RELATIVE AND COMBINED EFFECTS OF ABCIXIMAB AND STENTING ON REDUCTION OF ACUTE ISCHEMIC EVENTS AND LATE REVASCULARIZATION, Circulation, 98(17), 1998, pp. 4021-4021

Authors: LINCOFF AM MOLITERNO DJ ELLIS SG DEBOWEY D CABOT CF BOOTH JE GODFREY NK TOPOL EJ

Citation: Am. Lincoff et al., 6-MONTH ANGIOGRAPHIC OUTCOME WITH ABCIXIMAB AND STENTS - THE EPISTENTANGIOGRAPHIC SUBSTUDY, Circulation, 98(17), 1998, pp. 4028-4028

Authors: CHO L FOODY JM GODFREY NK

Citation: L. Cho et al., CONSISTENT BENEFIT OF ABCIXIMAB IIB IIIA BLOCKADE ACROSS GENDER - POOLED ANALYSIS FROM EPIC, EPILOG, AND EPISTENT/, Circulation, 98(17), 1998, pp. 4434-4434